Booster vaccination of healthy adults with VZV antibody but without a VZV-specific cell-mediated immune response.
D000367:Age Factors; D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis* / Q000276:immunology; D000956:Antigens, Viral / Q000276:immunology; D002644:Chickenpox / Q000276:immunology*; D004306:Dose-Response Relationship, Immunologic; D004311:Double-Blind Method; D014645:Herpesvirus 3, Human / Q000254:growth & development / Q000276:immunology* / Q000472:pathogenicity; D006801:Humans; D006968:Hypersensitivity, Delayed; D007117:Immunization, Secondary; D008213:Lymphocyte Activation; D008875:Middle Aged; D014613:Vaccines, Attenuated / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
D000914:Antibodies, Viral; D000956:Antigens, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines